Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZOM | Common Stock, without par value | Options Exercise | $32.5K | +125K | +10% | $0.26 | 1.38M | May 17, 2021 | Direct | |
transaction | ZOM | Common Stock, without par value | Sale | -$97K | -125K | -9.09% | $0.78 | 1.25M | May 17, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZOM | Stock option (right to buy) | Options Exercise | $0 | -125K | -50% | $0.00 | 125K | May 17, 2021 | Common Stock, without par value | 125K | $0.26 | Direct |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.763 to $0.788 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |